Catalyst Pharmaceuticals, Inc.

Contributing Author

Recent Articles by Catalyst Pharmaceuticals, Inc.

Oct-22	Catalyst Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 5, 2025 CPRX GlobeNewswire
Oct-09	Catalyst Pharmaceuticals Announces Presentations at Upcoming Scientific Conferences CPRX GlobeNewswire
Oct-01	Catalyst Pharmaceuticals Announces $200 Million Share Repurchase Program CPRX GlobeNewswire
Aug-28	Catalyst Pharmaceuticals to Participate in Upcoming Investor Conferences CPRX GlobeNewswire
Aug-26	UPDATED- Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE (amifampridine) Patent Litigation with Lupin Pharmaceuticals CPRX GlobeNewswire
Aug-25	Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE (amifampridine) Patent Litigation with Lupin Pharmaceuticals CPRX GlobeNewswire
Aug-06	Catalyst Pharmaceuticals Reports Record Second Quarter and First Half 2025 Financial Results; Provides Business Update CPRX GlobeNewswire
Aug-06	Lambert Eaton Myasthenic Syndrome (LEMS) Antibody Testing and Treatment Recommendations Added to NCCN Clinical Practice Guidelines for Small Cell Lung Cancer (SCLC) CPRX GlobeNewswire
Aug-04	Catalyst Pharmaceuticals Appoints Daniel Curran, MD, to its Board of Directors CPRX GlobeNewswire
Jul-22	Catalyst Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 6, 2025 CPRX GlobeNewswire
Jun-02	Catalyst Pharmaceuticals Announces Appointment of William T. Andrews, MD, FACP as Chief Medical Officer CPRX GlobeNewswire
May-07	Catalyst Pharmaceuticals Reports Record First Quarter 2025 Financial Results and Provides Business Update CPRX GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 Finviz.com. All Rights Reserved.